Cargando…
Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors
BACKGROUND: As our molecular understanding of pediatric central nervous system (CNS) tumors evolves, so too do diagnostic criteria, prognostic biomarkers, and clinical management decision making algorithms. Here, we explore the clinical utility of wide-breadth assays, including whole-exome sequencin...
Autores principales: | Rajappa, Prajwal, Eng, Kenneth W, Bareja, Rohan, Bander, Evan D, Yuan, Melissa, Dua, Alisha, Bhanu Maachani, Uday, Snuderl, Matija, Pan, Heng, Zhang, Tuo, Tosi, Umberto, Ivasyk, Iryna, Souweidane, Mark M, Elemento, Olivier, Sboner, Andreas, Greenfield, Jeffrey P, Pisapia, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034114/ https://www.ncbi.nlm.nih.gov/pubmed/35475276 http://dx.doi.org/10.1093/noajnl/vdac031 |
Ejemplares similares
-
PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models
por: Tosi, Umberto, et al.
Publicado: (2020) -
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy
por: Chang, Raymond, et al.
Publicado: (2019) -
Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors
por: Tosi, Umberto, et al.
Publicado: (2017) -
B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors
por: Maachani, Uday B., et al.
Publicado: (2019) -
Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells()
por: Wu, Y. Linda, et al.
Publicado: (2017)